Contact
searchSearch
HMP Global

News

News
Urban Residents With Arthritis Access More In-Person Care Than Rural Counterparts
04/24/2025
Lisa Kuhns, PhD, MD
Individuals with rheumatoid arthritis (RA) and osteoarthritis (OA) living in rural areas access significantly less in-person health care than those in urban settings, according to a study published in Arthritis Care & Research.
Individuals with rheumatoid arthritis (RA) and osteoarthritis (OA) living in rural areas access significantly less in-person health care than those in urban settings, according to a study published in Arthritis Care & Research.
Individuals with rheumatoid...
04/24/2025
First Report Managed Care
News
Continued Immunotherapy Beyond Progression May Extend Survival in Metastatic NSCLC
04/23/2025
Grace Taylor, MS, MA
Study finds extended survival with immunotherapy beyond disease progression for patients with non–small cell lung cancer.
Study finds extended survival with immunotherapy beyond disease progression for patients with non–small cell lung cancer.
Study finds extended survival...
04/23/2025
First Report Managed Care
News
New siRNA Shows Long-Term Efficacy and Enhanced Safety in Hemophilia A and B
04/21/2025
Grace Taylor, MS, MA
A long-term study reveals that fitusiran effectively rebalances hemostasis while reducing bleeding episodes in patients with hemophilia.
A long-term study reveals that fitusiran effectively rebalances hemostasis while reducing bleeding episodes in patients with hemophilia.
A long-term study reveals that...
04/21/2025
First Report Managed Care
News
Bone Health Screenings Underused in US Hemophilia Centers Despite High Risk
04/17/2025
Grace Taylor, MS, MA
Low screening rates for osteoporosis in people with hemophilia highlight a critical gap in preventative care at US federally funded hemophilia centers.
Low screening rates for osteoporosis in people with hemophilia highlight a critical gap in preventative care at US federally funded hemophilia centers.
Low screening rates for...
04/17/2025
First Report Managed Care
News
New Treatment for Vitiligo Offers Long-Term Cost Savings and High Repigmentation Success
04/14/2025
Lisa Kuhns, PhD, MD
A novel treatment for stable vitiligo combining autologous skin cell suspension (ASCS) with phototherapy has demonstrated both clinical success and long-term cost savings when compared to phototherapy alone, according to study results...
A novel treatment for stable vitiligo combining autologous skin cell suspension (ASCS) with phototherapy has demonstrated both clinical success and long-term cost savings when compared to phototherapy alone, according to study results...
A novel treatment for stable...
04/14/2025
First Report Managed Care
News
Fitusiran Shows Sustained Bleed Control and Safety With AT-Guided Dosing in Hemophilia
04/14/2025
Juliet Gallagher
Findings from a phase 2 open-label extension study suggest that fitusiran, a small interfering RNA (siRNA) therapy targeting antithrombin (AT), offers sustained bleeding control and quality of life improvements in people with moderate or...
Findings from a phase 2 open-label extension study suggest that fitusiran, a small interfering RNA (siRNA) therapy targeting antithrombin (AT), offers sustained bleeding control and quality of life improvements in people with moderate or...
Findings from a phase 2...
04/14/2025
First Report Managed Care
News
Fixed-Duration Mosunetuzumab Offers Effective and Budget-Friendly Option for Relapsed Follicular Lymphoma
04/14/2025
Lisa Kuhns, PhD, MD
Mosunetuzumab adds a highly effective, fixed-duration treatment option for patients with relapsed or refractory (R/R) follicular lymphoma (FL), with minimal financial impact to payers.
Mosunetuzumab adds a highly effective, fixed-duration treatment option for patients with relapsed or refractory (R/R) follicular lymphoma (FL), with minimal financial impact to payers.
Mosunetuzumab adds a highly...
04/14/2025
First Report Managed Care
News
Expert Panel Calls for Improved Utilization of Biosimilar Anti-TNF-α Therapies in IBD to Enable Earlier, More Effective Treatment
04/11/2025
Hannah Musick
Researchers urge for the broader use of biosimilar anti-TNF-α therapies in irritable bowel disease (IBD) to support earlier, more effective treatment and improve long-term outcomes, emphasizing the need for targeted clinician and patient...
Researchers urge for the broader use of biosimilar anti-TNF-α therapies in irritable bowel disease (IBD) to support earlier, more effective treatment and improve long-term outcomes, emphasizing the need for targeted clinician and patient...
Researchers urge for the broader...
04/11/2025
First Report Managed Care
News
Study Quantifies How Social and Structural Factors Drive Racial Inequities in NSCLC Care
04/11/2025
Lisa Kuhns, PhD, MD
Black patients with non-small cell lung cancer (NSCLC) in the US experience significantly worse care and outcomes compared with White patients, and these disparities are largely explained by exposure to structural racism across the health...
Black patients with non-small cell lung cancer (NSCLC) in the US experience significantly worse care and outcomes compared with White patients, and these disparities are largely explained by exposure to structural racism across the health...
Black patients with non-small...
04/11/2025
First Report Managed Care
News
MUSETTE Trial Confirms Optimal Dosing of Ocrelizumab for Relapsing MS
04/10/2025
Danielle Sposato
In a recent press release, Genentech has announced results from the phase 3 MUSETTE trial (NCT04544436), which evaluated higher doses of intravenous (IV) ocrelizumab (Ocrevus) in patients with relapsing multiple sclerosis (RMS).
In a recent press release, Genentech has announced results from the phase 3 MUSETTE trial (NCT04544436), which evaluated higher doses of intravenous (IV) ocrelizumab (Ocrevus) in patients with relapsing multiple sclerosis (RMS).
In a recent press release,...
04/10/2025
First Report Managed Care

Behind the Bill

Behind the Bill
The Medicare Paradox: How Tariffs Could Undermine IRA Drug Pricing Reforms
04/23/2025
Katie Hayes, MJ
The Trump administration's recent announcement of national security investigations into pharmaceutical imports has set up a potential collision course with one of the most significant health care reforms in recent years. While the White...
The Trump administration's recent announcement of national security investigations into pharmaceutical imports has set up a potential collision course with one of the most significant health care reforms in recent years. While the White...
The Trump administration's...
04/23/2025
First Report Managed Care
Behind the Bill
The Bitter Pill, Now in Motion: Pharma Tariffs Move from Rhetoric to Reality
04/16/2025
Katie Hayes, MJ
Last week, I flagged the growing risk that tariffs could upend affordability in the generics market. This week, the Trump administration made it official: it’s launching national security investigations under Section 232 of the Trade...
Last week, I flagged the growing risk that tariffs could upend affordability in the generics market. This week, the Trump administration made it official: it’s launching national security investigations under Section 232 of the Trade...
Last week, I flagged the growing...
04/16/2025
First Report Managed Care
Behind the Bill
The Bitter Pill: How Tariffs Could Make Generics Less Affordable
04/09/2025
Katie Hayes, MJ
As President Donald Trump’s administration introduces a series of tariffs aimed at rebalancing trade and boosting US manufacturing, one sector in particular is watching closely: pharmaceuticals. While drugs themselves may not be directly...
As President Donald Trump’s administration introduces a series of tariffs aimed at rebalancing trade and boosting US manufacturing, one sector in particular is watching closely: pharmaceuticals. While drugs themselves may not be directly...
As President Donald Trump’s...
04/09/2025
First Report Managed Care
Behind the Bill
SCOTUS Takes on the Nondelegation Doctrine: Surprising Reactions and What They Mean for Agency Power
04/02/2025
Katie Hayes, MJ
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard arguments in Federal Communication Commission (FCC) v Consumers’ Research, a case that I covered in February and one that could dramatically reshape federal agency authority through the nondelegation...
The Supreme Court recently heard...
04/02/2025
First Report Managed Care
Behind the Bill
Dr Oz’s Prescription for Making Medicaid “Viable at Every Level”
03/26/2025
Katie Hayes, MJ
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the Senate Finance Committee voted to advance Dr Mehmet Oz in his confirmation as the next head of the Centers for Medicare and Medicaid Services (CMS).1 The full Senate vote is expected “soon” (whatever that...
On Tuesday, March 25, 2025, the...
03/26/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question Continues: Dr Oz's Confirmation and the Future of Medicaid
03/19/2025
Katie Hayes, MJ
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880 billion question facing Congress—whether lawmakers could achieve their budget goals without cutting Medicaid. This week, that question took center stage as Dr Mehmet Oz, President Trump's nominee to lead the...
Last week, I explored the $880...
03/19/2025
First Report Managed Care
Behind the Bill
The $880 Billion Question: Can Congress Cut Spending Without Touching Medicaid?
03/12/2025
Katie Hayes, MJ
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from administrative law for a moment to provide a quick update on Medicaid. With news coming from all sides, what does the future of Medicaid actually look like? The House of Representatives narrowly passed a budget...
I’d like to step away from...
03/12/2025
First Report Managed Care
Behind the Bill
RFK Jr’s Public Comment Ban: The Silent Shift in Health Care Rulemaking
03/05/2025
Katie Hayes, MJ
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative law continues, and with it, the dismantling of decades-long precedent. In June, the Supreme Court overturned a 40-year-old doctrine that allowed federal agencies to interpret their own ambiguous statutes. Later...
The erosion of administrative...
03/05/2025
First Report Managed Care
Behind the Bill
Prevention Over Pills? The First 2 Weeks of Health Care’s New Direction
02/26/2025
Katie Hayes, MJ
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from Robert F Kennedy Jr’s confirmation as Secretary of Health and Human Services (HHS), but the changes are already coming fast and furious—a key theme of the Trump Administration’s actions within the last several...
The dust has barely settled from...
02/26/2025
First Report Managed Care
Behind the Bill
The Nondelegation Doctrine: The Next Constitutional Showdown (Part 2)
02/19/2025
Katie Hayes, MJ
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the potential revival of the nondelegation doctrine through Federal Communication Commission v Consumers’ Research. Today, I want to examine what this could mean for health care regulation by considering the parallels...
Last week, I explored the...
02/19/2025
First Report Managed Care

Subscribe and Stay Ahead With Daily Industry Insights

First Report Managed Care Newsletter

Trending Articles

News
Cardiovascular Disease Increases Rate of Cognitive Decline in People With MS
05/18/2023
Jolynn Tumolo
In light of their findings, researchers recommended shortening the cognitive decline evaluation period from 1 year to 6 months for patients with multiple sclerosis.
In light of their findings, researchers recommended shortening the cognitive decline evaluation period from 1 year to 6 months for patients with multiple sclerosis.
In light of their findings,...
05/18/2023
First Report Managed Care
News
Interleukin-17 Inhibitors May Improve Psoriasis Symptoms When TNF Inhibitors Do Not
06/08/2023
Jolynn Tumolo
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17 inhibitor may improve psoriasis symptoms for patients who discontinue a tumor necrosis factor inhibitor due to a lack of response.
Switching to an interleukin-17...
06/08/2023
First Report Managed Care
News
Digital Therapeutic Supports Recovery Among Patients With SUD 
07/05/2023
Julie Gould
A phone application provided cognitive behavioral therapy and recovery support services for individuals with substance use disorder, according to new findings.
A phone application provided cognitive behavioral therapy and recovery support services for individuals with substance use disorder, according to new findings.
A phone application provided...
07/05/2023
First Report Managed Care
Amy McMichael, MD
Videos
The 411 on Vitiligo: Treatment Updates and More
07/28/2023
Amy J. McMichael, MD
Amy McMichael, MD, Department of Dermatology, Wake Forest School of Medicine, discusses the latest treatment updates in vitiligo and provides need-to-know information for providers.
Amy McMichael, MD, Department of Dermatology, Wake Forest School of Medicine, discusses the latest treatment updates in vitiligo and provides need-to-know information for providers.
Amy McMichael, MD, Department of...
07/28/2023
First Report Managed Care
News
Dry Eye Disease Corneal Pain, Past Treatment Associated with Poorer Quality of Life
08/24/2023
Jolynn Tumolo
A recent study examining the impact of dry eye disease on quality of life in a real-world DED population found that factors such as mixed DED, corneal neuropathic pain, and prior treatment were associated with worse symptoms and QoL. 
A recent study examining the impact of dry eye disease on quality of life in a real-world DED population found that factors such as mixed DED, corneal neuropathic pain, and prior treatment were associated with worse symptoms and QoL. 
A recent study examining the...
08/24/2023
First Report Managed Care

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2025 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Term of Use